Positron emission tomography studies on D-2 dopamine receptor occupancy and plasma antipsychotic drug levels in man

被引:63
作者
Nyberg, S
Nordstrom, AL
Halldin, C
Farde, L
机构
[1] Karolinska Institute, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Stockholm
关键词
positron emission tomography; human; D-2 dopamine receptors; neuroleptics; plasma concentrations; dose-response relationship;
D O I
10.1097/00004850-199509000-00011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Positron emission tomography (PET) and the selective radioligand [C-11]raclopride were used to measure D-2 receptor occupancy in several studies in schizophrenic patients and healthy subjects, Clinical effects of the treatment were recorded, and drug plasma concentrations measured. The hypothesized curvilinear relationship between receptor occupancy and drug plasma concentrations was supported experimentally. We suggest that there may be a distinct threshold for antipsychotic effect at about 70% D-2 receptor occupancy, and another threshold for extrapyramidal side effects above 808 D-2 receptor occupancy. Receptor occupancy was high even at low plasma drug concentrations. Our data indicate a need to establish dose-response curves for the conventional neuroleptics. Such a dose-response relationship might be expected for a much lower dose interval than those previously examined.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 28 条
[1]  
AUBREE JC, 1980, J CLIN PSYCHIAT, V41, P341
[2]   A SURVEY OF DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS [J].
AYD, FJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 175 (12) :1054-&
[3]  
BALDESSARINI RJ, 1988, ARCH GEN PSYCHIAT, V45, P79
[4]   STRIATAL DOPAMINE RECEPTOR OCCUPANCY DURING AND FOLLOWING WITHDRAWAL FROM NEUROLEPTIC TREATMENT - CORRELATIVE EVALUATION BY POSITRON EMISSION TOMOGRAPHY AND PLASMA PROLACTIN LEVELS [J].
BARON, JC ;
MARTINOT, JL ;
CAMBON, H ;
BOULENGER, JP ;
POIRIER, MF ;
CAILLARD, V ;
BLIN, J ;
HURET, JD ;
LOCH, C ;
MAZIERE, B .
PSYCHOPHARMACOLOGY, 1989, 99 (04) :463-472
[5]   LOW-DOSE DEPOT MEDICATION IN SCHIZOPHRENIA [J].
BURNETT, PL ;
GALLETLY, CA ;
MOYLE, RJ ;
CLARK, CR .
SCHIZOPHRENIA BULLETIN, 1993, 19 (01) :155-164
[6]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[7]   INVIVO ASSAY FOR NEUROLEPTIC RECEPTOR-BINDING IN THE STRIATUM - POSITRON TOMOGRAPHY IN HUMANS [J].
CAMBON, H ;
BARON, JC ;
BOULENGER, JP ;
LOCH, C ;
ZARIFIAN, E ;
MAZIERE, B .
BRITISH JOURNAL OF PSYCHIATRY, 1987, 151 :824-830
[8]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[9]  
DAVIS JM, 1975, AM J PSYCHIAT, V132, P1237
[10]  
FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71